Priority Date: 09.11.12 (US 201261724484P)

ANTI-ADAM28 ANTIBODY FOR TREATING CANCER

  • Application ID: EP18211128
  • Status: The application has been published

Applicant

Research organisation logo small
Research Organisation

Attorney

Employment test 51 - 200 employees
Company dna j a kemp
no operation time available
1345.74
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC combination A61, C07, and C12. J A Kemp is specialized in the combination A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 127 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 09.11.2012 - Priority Date (US 201261724484P)
  • 24.04.2019 - Publication A1 (EP3473718)